Literature DB >> 15254966

Effect of recombinant porcine IGFBP-3 on IGF-I and long-R3-IGF-I-stimulated proliferation and differentiation of L6 myogenic cells.

G Xi1, E Kamanga-Sollo, M S Pampusch, M E White, M R Hathaway, William R Dayton.   

Abstract

Insulin-like growth factor (IGF)-I stimulates both proliferation and differentiation of myogenic precursor cells. In vivo, IGFs are bound to one of the members of a family of six high-affinity IGF binding proteins (IGFBP 1-6) that regulate their biological activity. One of these binding proteins, IGFBP-3, affects cell proliferation via both IGF-dependent and IGF-independent mechanisms and it has generally been shown to suppress proliferation of cultured cells; however, it also may stimulate proliferation depending upon the cell type and the assay conditions. Cultured porcine embryonic myogenic cells (PEMCs) produce IGFBP-3 and its level drops significantly immediately prior to differentiation. Additionally, IGFBP-3 suppresses both IGF-I and Long-R3-IGF-I-stimulated proliferation of embryonic porcine myogenic cells. In this study, we have examined the effects of recombinant porcine IGFBP-3 (rpIGFBP-3) on IGF-I- and Long-R3-IGF-I-stimulated proliferation and differentiation of the L6 myogenic cell line. L6 cells potentially provide a good model for studying the actions of IGFBP-3 on muscle because they contain no non-muscle cells and they do not produce detectable levels of IGFBP-3. RpIGFBP-3 suppresses both IGF-I and Long-R3-IGF-I-stimulated proliferation of L6 cells, indicating that it suppresses proliferation via both IGF-dependent and IGF-independent mechanisms. Our data also show that rpIGFBP-3 causes IGF-independent suppression of proliferation without increasing the level of phosphosmad-2 in L6 cultures. Additionally, rpIGFBP-3 suppresses IGF-I-stimulated differentiation of L6 cells. In contrast, however, rpIGFBP-3 does not suppress Long-R3-IGF-I-stimulated differentiation. This suggests that rpIGFBP-3 does not have IGF-independent effects on L6 cell differentiation. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254966     DOI: 10.1002/jcp.20068

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Pregnancy-associated plasma protein-A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism.

Authors:  Ashok Kumar; Subburaman Mohan; Jacqueline Newton; Mark Rehage; Kiet Tran; David J Baylink; Xuezhong Qin
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

2.  EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I.

Authors:  Munenori Takaoka; Caitlin E Smith; Michael K Mashiba; Takaomi Okawa; Claudia D Andl; Wafik S El-Deiry; Hiroshi Nakagawa
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-10-06       Impact factor: 4.052

3.  Apposite insulin-like growth factor (IGF) receptor glycosylation is critical to the maintenance of vascular smooth muscle phenotype in the presence of factors promoting osteogenic differentiation and mineralization.

Authors:  Kirk W Siddals; Justine Allen; Smeeta Sinha; Ann E Canfield; Philip A Kalra; J Martin Gibson
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

Review 4.  Clinical, agricultural, and evolutionary biology of myostatin: a comparative review.

Authors:  Buel D Rodgers; Dilip K Garikipati
Journal:  Endocr Rev       Date:  2008-06-30       Impact factor: 19.871

5.  Mature IGF-I excels in promoting functional muscle recovery from disuse atrophy compared with pro-IGF-IA.

Authors:  Soohyun Park; Becky K Brisson; Min Liu; Janelle M Spinazzola; Elisabeth R Barton
Journal:  J Appl Physiol (1985)       Date:  2013-12-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.